Delton Technology (01989) has announced plans to utilize H-share proceeds to inject $16 million into its wholly-owned subsidiary, Guanghe Technology (International) Co., Ltd. (referred to as "Guanghe International"). The capital infusion is intended to support the pursuit of future strategic collaborations, investment opportunities, or acquisitions.

Additionally, to facilitate the second-phase construction of the company's Thailand manufacturing base—a project funded by H-share proceeds—Delton will allocate another $80 million to Guanghe International. Guanghe International, together with Delton Investment Holdings Limited (referred to as "Delton Holdings"), will then contribute a total of $80 million to Delton Technology (Thailand) Co., Ltd. (referred to as "Delton Thailand") in proportion to their respective equity interests.

This capital increase is part of the company’s implementation of its H-share fundraising projects. It aims to help the company seize opportunities in industry consolidation, optimize its industrial layout, accelerate the second-phase construction of the Thailand base, expand overseas high-end PCB production capacity, and enhance its competitiveness in the global market.

The injection will be funded entirely from the company’s overseas H-share proceeds and will not affect its core business operations or existing capital utilization arrangements. The move does not harm the interests of the company or its shareholders, particularly minority shareholders.

The company is adhering strictly to the H-share prospectus and the fundraising utilization plan. The capital injection does not alter the intended use of the raised funds.